理解印度残障、跨性别与性别多元群体在新冠疫苗可及性与接种中的结构性不平等
研究采用参与式定性方法,访谈印度跨性别与性别多元(TGD)及残障群体、关键利益相关方和卫生系统代表共45人,以社会生态模型和交叉性视角进行归纳主题分析。结果显示,尽管多数参与者有意接种,信息沟通缺口、疫苗登记、数据收集、交通、基础设施及疫苗中心实际或预期的恶劣对待等结构性障碍影响了两群体的疫苗可及性,且与既往卫生系统经历相呼应。
要点
- 多数参与者有意接种新冠疫苗,但多种结构性障碍限制了TGD与残障群体的疫苗可及性。
- 障碍包括信息沟通缺口、登记与数据收集困难、交通与基础设施障碍及疫苗中心的恶劣对待。
- 作者认为应将疫苗犹豫置于社会历史边缘化背景中理解,并呼吁卫生系统公平回应两群体需求。
核心结论
- 研究揭示印度新冠疫苗接种规划在设计、实施与外展中存在的卫生系统结构性不平等。
- 作者认为应超越疫苗犹豫框架,重视TGD与残障群体边缘化的社会历史背景,并倡导卫生系统公平回应其疫苗接种与健康需求。
- 作者指出两群体部分挑战各有不同,但共同被公共系统排斥的经历可为跨运动倡导与团结提供空间,并有助于卫生系统改革。
研究设计与样本
- 采用参与式定性研究方法,TGD与残障个体全程参与并接受咨询。
- 访谈45名来自TGD与残障群体的人士以及参与印度疫苗接种推行的其他关键利益相关方和卫生系统代表。
- 采用社会生态模型与交叉性方法指导的归纳主题分析。
主要发现
- 多数参与者有意接种疫苗,但多种结构性障碍影响TGD与残障群体的新冠疫苗可及性。
- 障碍包括针对两群体特定健康需求的信息与沟通缺口,以及疫苗登记、数据收集、交通、基础设施方面的障碍。
- 障碍还包括疫苗中心实际或预期的恶劣对待。
- 每一新出现的疫苗接种结构性缺口均可在既往卫生系统经历中找到对应,反映卫生及相关系统长期普遍存在的不平等。
临床怎么用
- 原文未据此给出临床实践推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Undervaccination and vaccination-related anxieties among marginalised communities like the transgender and gender-diverse (TGD) and disability communities are underexplored in the Indian context. Our study seeks to understand the role of structural and historical inequities in shaping COVID-19 vaccine access for the two communities in India. METHODS: Using a participatory qualitative research approach, TGD and disabled individuals were involved in and consulted throughout the research process. We interviewed 45 individuals for our study, hailing from the two communities and other key stakeholders and health system representatives involved in vaccination roll-out in India. We conducted an inductive thematic analysis guided by the socio-ecological model and intersectionality approach. RESULTS: Despite intent to get vaccinated among most participants, several structural barriers shaped COVID-19 vaccine access for people from the TGD and disability community. This included information and communication gaps with respect to the specific health needs of the two communities, barriers related to vaccine registration, data collection, transport, infrastructure and actual or anticipated mistreatment at vaccine centres. Each emergent structural gap in vaccination had parallels in past health systems experiences, pointing to the longstanding and pervasive inequities within health and allied systems which impact how communities perceive and respond to new health system interventions. CONCLUSION: This study uncovers the structural inequities within health systems that have permeated the planning, design and outreach of COVID-19 vaccination programs in India. Moving beyond notions of vaccine hesitancy among the TGD and disability community, we underscore the importance of socio-historical contexts of marginalisation and advocate for systems to recognise these contexts and respond equitably to the vaccination and health needs of the two communities. While some challenges among the two communities were distinct, the study explores how a shared experience of exclusion from public systems can provide avenues for cross-movement advocacy and solidarity, and help inform health system reforms.
引用
- D'souza S, Ghatole B, Raghuram H, et al. Understanding structural inequities in Covid-19 vaccine access and uptake among disability, transgender and gender-diverse communities in India. Vaccine. 2024. PMID: 39117525. doi:10.1016/j.vaccine.2024.126174
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。